We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ensign Group Boosts U.S. Presence With Idaho and Texas Facility Buyouts
Read MoreHide Full Article
Key Takeaways
ENSG acquired operations and real estate of a 120-bed skilled nursing facility in Boise, ID.
Standard Bearer bought a 124-bed Texas facility, leased to a third party under a triple net lease.
ENSG now operates 348 healthcare sites and owns 146 real estate assets across 17 U.S. states.
The Ensign Group, Inc. (ENSG - Free Report) recently purchased the real estate and operations of a Boise, ID-based skilled nursing facility, Timber Springs Transitional Care. Equipped with 120 beds, the real estate was acquired through a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company. The facility will now be operated by a tenant entity affiliated with Ensign.
Concurrently, the unit of Standard Bearer purchased the real estate of Duncanville, TX-based Duncanville Healthcare and Rehabilitation Center. This 124-bed skilled nursing facility will be operated by a third party under a long-term triple net lease arrangement. Both the Idaho and Texas acquisitions have already been effective from the very beginning of July 2025.
By collaborating closely with dedicated caregiver teams at its newly acquired facilities, ENSG will deepen its understanding of the unique needs of local communities, enabling it to deliver enhanced, patient-centered care to residents and their families.
Following the most recent acquisitions, Ensign Group's portfolio now includes 348 healthcare operations spread across 17 states, with 44 locations also offering senior living services. Additionally, through its subsidiaries—including Standard Bearer—the company owns 146 real estate assets. Around a month before the latest Idaho buyout, ENSG also conducted acquisitions in the state. It purchased the operations of two skilled nursing facilities located in Coeur d’Alene, Ironwood Rehabilitation and Care Center and Lakeside Rehabilitation and Care Center. The facilities are equipped with 80 and 100 beds, respectively.
Ensign Group's Motive Behind Such Expansion Efforts
The year 2025 so far has been quite active for the company on the acquisition front. Its steady stream of acquisitions has significantly enhanced its ability to expand into numerous U.S. communities, leading to a strong nationwide presence and addressing critical gaps in care availability and providing much-needed support to underserved populations.
Management keeps an eye on detecting opportunistic real-estate buyouts. It also aims to lease struggling skilled nursing, senior living and other healthcare-linked businesses across the United States.
An increase in the number of skilled nursing facilities as a result of moves similar to Idaho facility buyout allows the healthcare provider to serve a broader patient population, which can, in turn, fuel strong revenue growth within its Skilled Services segment. This segment derives income from multiple channels, including Medicaid, Medicare, managed care programs and private payors. Historically, Skilled Services has been a major contributor to ENSG’s total revenues, accounting for 97.5% of its revenues in the first quarter of 2025.
Meanwhile, the Texas-based facility acquisition is expected to boost rental income of Ensign Group that it earns through its Standard Bearer division. Such income is generated by leasing post-acute care properties acquired from healthcare operators under triple-net lease agreements. These arrangements are advantageous for the company, as it not only earns rental revenues but also shifts property-related expenses to the tenants.
ENSG’s Share Price Performance & Zacks Rank
Shares of Ensign Group have gained 17.8% in the past year compared with the industry’s 12.5% growth. ENSG currently carries a Zacks Rank #2 (Buy).
BrightSpring Health’s earnings surpassed estimates in two of the last four quarters and missed the mark twice, the average surprise being 17.49%. The Zacks Consensus Estimate for BTSG’s 2025 earnings indicates a rise of 55.4% from the 2024 figure. The consensus mark for revenues implies an improvement of 9.1% from the 2024 figure. The consensus mark for BTSG’s 2025 earnings has moved 38.1% north in the past 60 days.
The bottom line of BioCryst Pharmaceuticals outpaced estimates in two of the trailing four quarters, matched the mark once and missed the same in the remaining one occasion, the average surprise being 12.94%. The Zacks Consensus Estimate for BCRX’s 2025 earnings is pegged at 12 cents per share. A loss of 42 cents per share was incurred in the prior year. The consensus mark for revenues implies an improvement of 34.9% from the 2024 figure. BCRX has witnessed six upward estimate revisions for 2025 earnings against none down in the past 60 days.
BioLife Solutions’ earnings surpassed estimates in each of the last four quarters, the average surprise being 112.90%. The Zacks Consensus Estimate for BLFS’ 2025 earnings is pegged at two cents per share. A loss of seven cents per share was incurred in the prior year. BLFS has witnessed one upward estimate revision for 2025 earnings against none down in the past 60 days.
Shares of BrightSpring Health, BioCryst Pharmaceuticals and BioLife Solutions have gained 94.6%, 38.8% and 14.3%, respectively, in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Ensign Group Boosts U.S. Presence With Idaho and Texas Facility Buyouts
Key Takeaways
The Ensign Group, Inc. (ENSG - Free Report) recently purchased the real estate and operations of a Boise, ID-based skilled nursing facility, Timber Springs Transitional Care. Equipped with 120 beds, the real estate was acquired through a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company. The facility will now be operated by a tenant entity affiliated with Ensign.
Concurrently, the unit of Standard Bearer purchased the real estate of Duncanville, TX-based Duncanville Healthcare and Rehabilitation Center. This 124-bed skilled nursing facility will be operated by a third party under a long-term triple net lease arrangement. Both the Idaho and Texas acquisitions have already been effective from the very beginning of July 2025.
By collaborating closely with dedicated caregiver teams at its newly acquired facilities, ENSG will deepen its understanding of the unique needs of local communities, enabling it to deliver enhanced, patient-centered care to residents and their families.
Following the most recent acquisitions, Ensign Group's portfolio now includes 348 healthcare operations spread across 17 states, with 44 locations also offering senior living services. Additionally, through its subsidiaries—including Standard Bearer—the company owns 146 real estate assets. Around a month before the latest Idaho buyout, ENSG also conducted acquisitions in the state. It purchased the operations of two skilled nursing facilities located in Coeur d’Alene, Ironwood Rehabilitation and Care Center and Lakeside Rehabilitation and Care Center. The facilities are equipped with 80 and 100 beds, respectively.
Ensign Group's Motive Behind Such Expansion Efforts
The year 2025 so far has been quite active for the company on the acquisition front. Its steady stream of acquisitions has significantly enhanced its ability to expand into numerous U.S. communities, leading to a strong nationwide presence and addressing critical gaps in care availability and providing much-needed support to underserved populations.
Management keeps an eye on detecting opportunistic real-estate buyouts. It also aims to lease struggling skilled nursing, senior living and other healthcare-linked businesses across the United States.
An increase in the number of skilled nursing facilities as a result of moves similar to Idaho facility buyout allows the healthcare provider to serve a broader patient population, which can, in turn, fuel strong revenue growth within its Skilled Services segment. This segment derives income from multiple channels, including Medicaid, Medicare, managed care programs and private payors. Historically, Skilled Services has been a major contributor to ENSG’s total revenues, accounting for 97.5% of its revenues in the first quarter of 2025.
Meanwhile, the Texas-based facility acquisition is expected to boost rental income of Ensign Group that it earns through its Standard Bearer division. Such income is generated by leasing post-acute care properties acquired from healthcare operators under triple-net lease agreements. These arrangements are advantageous for the company, as it not only earns rental revenues but also shifts property-related expenses to the tenants.
ENSG’s Share Price Performance & Zacks Rank
Shares of Ensign Group have gained 17.8% in the past year compared with the industry’s 12.5% growth. ENSG currently carries a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Other Stocks to Consider
Some other top-ranked stocks in the Medical space are BrightSpring Health Services, Inc. (BTSG - Free Report) , BioCryst Pharmaceuticals, Inc. (BCRX - Free Report) and BioLife Solutions, Inc. (BLFS - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
BrightSpring Health’s earnings surpassed estimates in two of the last four quarters and missed the mark twice, the average surprise being 17.49%. The Zacks Consensus Estimate for BTSG’s 2025 earnings indicates a rise of 55.4% from the 2024 figure. The consensus mark for revenues implies an improvement of 9.1% from the 2024 figure. The consensus mark for BTSG’s 2025 earnings has moved 38.1% north in the past 60 days.
The bottom line of BioCryst Pharmaceuticals outpaced estimates in two of the trailing four quarters, matched the mark once and missed the same in the remaining one occasion, the average surprise being 12.94%. The Zacks Consensus Estimate for BCRX’s 2025 earnings is pegged at 12 cents per share. A loss of 42 cents per share was incurred in the prior year. The consensus mark for revenues implies an improvement of 34.9% from the 2024 figure. BCRX has witnessed six upward estimate revisions for 2025 earnings against none down in the past 60 days.
BioLife Solutions’ earnings surpassed estimates in each of the last four quarters, the average surprise being 112.90%. The Zacks Consensus Estimate for BLFS’ 2025 earnings is pegged at two cents per share. A loss of seven cents per share was incurred in the prior year. BLFS has witnessed one upward estimate revision for 2025 earnings against none down in the past 60 days.
Shares of BrightSpring Health, BioCryst Pharmaceuticals and BioLife Solutions have gained 94.6%, 38.8% and 14.3%, respectively, in the past year.